Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

This study evaluates the safety and efficacy of different formulations of bimatoprost ophthalmic solution compared with Bimatoprost 0.03% once-daily in patients with glaucoma or ocular hypertension. One of the test formulations was given to one eye and bimatoprost 0.03% given to the fellow eye of each patient

Inclusion Criteria:

• Ocular hypertension or glaucoma in both eyes
• Require IOP-lowering therapy in each eye

Exclusion Criteria:

• Uncontrolled systemic disease
• Known allergy or hypersensitivity to bimatoprost